|
SAP130 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63669078290241E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.68349795110134E-12 |
| Normal-vs-Stage2 |
2.06510000000382E-06 |
| Normal-vs-Stage3 |
2.15016893179154E-12 |
| Normal-vs-Stage4 |
5.16420017859787E-10 |
| Stage1-vs-Stage2 |
7.493400E-01 |
| Stage1-vs-Stage3 |
1.222230E-01 |
| Stage1-vs-Stage4 |
2.517200E-01 |
| Stage2-vs-Stage3 |
1.917200E-01 |
| Stage2-vs-Stage4 |
2.503200E-01 |
| Stage3-vs-Stage4 |
9.675600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47659662275146E-14 |
| Normal-vs-AfricanAmerican |
1.579100E-03 |
| Normal-vs-Asian |
4.70609999969618E-07 |
| Caucasian-vs-AfricanAmerican |
1.270430E-01 |
| Caucasian-vs-Asian |
3.176400E-01 |
| AfricanAmerican-vs-Asian |
4.791400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13119957845242E-10 |
| Normal-vs-Female |
1.66244795707371E-12 |
| Male-vs-Female |
9.434800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.37759828386675E-11 |
| Normal-vs-Age(41-60Yrs) |
6.31183993959894E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68780545095615E-11 |
| Normal-vs-Age(81-100Yrs) |
2.172700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.475200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.839600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.214000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.689800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.778000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.302400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.672400E-02 |
| Classical-VS-Follicular |
1.126010E-01 |
| Classical-VS-Other |
1.736600E-01 |
| Classical-VS-Normal |
5.01598762525646E-12 |
| Tall-VS-Follicular |
4.236000E-01 |
| Tall-VS-Other |
8.427000E-01 |
| Tall-VS-Normal |
1.55160000403498E-08 |
| Follicular-VS-Other |
5.459600E-01 |
| Follicular-VS-Normal |
1.56780000093448E-09 |
| Other-VS-Normal |
6.437000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21870299910165E-11 |
| Normal-vs-N1 |
2.15200079978217E-11 |
| N0-vs-N1 |
4.274400E-02 |
|
|
